Retraction
The traditional Tibetan medicine Yukyung Karne exhibits a potent anti-metastatic activity by inhibiting the epithelial to mesenchymal transition and cell migration
Paper Information
Record ID:
44428
Author(s):
Publication Date:
June 13, 2015
Retraction Date:
March 22, 2023
(2.7 years years ago)
Subjects:
Institutions:
Country:
🇮🇳 IndiaArticle Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (9)
9
Total Citations2
Post-Retraction(22.2%)
6
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
0
After 2+ years
167
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM)
Xiaobing Yang, Di Lu, Yanfei Sun et al. (14 authors)
Frontiers in Oncology
Open Access
Published: Sep 2023
3 citations
3 citations
167 days after retraction
Retraction Note: Molecular insights into the anti-cancer properties of Traditional Tibetan medicine Yukyung Karne
Tenzin Choedon, Dawa Dolma, Mathan Ganeshan et al. (4 authors)
BMC Complementary Medicine and Therapies
Open Access
Published: Mar 2023
8 days after retraction
Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: A comprehensive review
Rakshandha Saini, Nitin Sharma, Oluwole Solomon Oladeji et al. (8 authors)
Journal of Ethnopharmacology
Published: Sep 2021
133 citations
133 citations
566 days before retraction
Role of ceramide/sphingomyelin (SM) balance regulated through “SM cycle” in cancer
Makoto Taniguchi, Toshiro Okazaki
Cellular Signalling
Open Access
Published: Aug 2021
86 citations
86 citations
580 days before retraction
2‐Aminoaryl‐3,5‐diaryl pyrazines: Synthesis, biological evaluation against <i>Mycobacterium tuberculosis</i> and docking studies
Nagaraja Reddy Gangarapu, Archakam Ranganatham, Eeda Koti Reddy et al. (5 authors)
Archiv der Pharmazie
Published: May 2020
1 citation
1 citation
1044 days before retraction
Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer
Vinoth Prasanna Gunasekaran, Kumari Nishi, Dakshinamurthy Sivakumar et al. (5 authors)
European Journal of Pharmaceutical Sciences
Published: Sep 2017
19 citations
19 citations
2017 days before retraction
Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms
Bhavesh C. Variya, Anita K. Bakrania, Snehal S. Patel
Pharmacological Research
Published: Jun 2016
244 citations
244 citations
2471 days before retraction
Serpine2, a potential novel target for combating melanoma metastasis.
Qi Wu
PubMed
Published: Jan 2016
33 citations
33 citations
2637 days before retraction
Quick Stats
Total Citations:
17
Years Since Retraction:
2.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025